A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Vendors market the substance there before directing customers to other platforms for transactions.
This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.
Several experts said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or prison.
Based on the social media company, the service has taken down violative content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.
Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, populated with photos of slimming results, positive reviews and detailed guides for mixing or injecting at residence.
After minutes of entering one community, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, health issues or previous experience.
Inside these groups, messages display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.
A spokesperson for the messaging service said it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
“People are injecting substances they cannot confirm. Although the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.
Her team has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose users to potentially serious health risks”.
Marcus Sterling is a financial analyst specializing in precious metals, with over 15 years of experience in global markets and investment strategies.